{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:05:34Z","timestamp":1780031134033,"version":"3.53.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to evaluate whether the fibrinogen\u2212to\u2212albumin ratio (FAR) provides incremental prognostic value for identifying preeclamptic patients at high risk of adverse peripartum events, defined as a composite adverse perinatal outcome (CAPO) that serves as a surrogate for severe disease burden, and to explore its potential utility in guiding anesthesia\u2212relevant decisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This dual\u2212center retrospective cohort study included 924 preeclamptic patients from two tertiary referral hospitals. Patients from center A (\n                      <jats:italic>n<\/jats:italic>\n                      = 680) were randomly allocated in a 7:3 ratio to a training cohort (\n                      <jats:italic>n<\/jats:italic>\n                      = 476) and an internal validation cohort (\n                      <jats:italic>n<\/jats:italic>\n                      = 204). Patients from center B (\n                      <jats:italic>n<\/jats:italic>\n                      = 244) constituted an independent external validation cohort. CAPO was defined as the occurrence of placental abruption, preterm birth, fetal growth restriction, fetal distress, neonatal respiratory distress syndrome, 5\u2212min Apgar score below 7, neonatal intensive care unit admission, or perinatal death. Candidate predictors were identified using forward stepwise logistic regression. Model A (the base model) incorporated established predictors including the sFlt\u22121\/PlGF ratio. Model B (the extended model) was developed by adding FAR. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), calibration plots, and Brier scores. Incremental value was quantified by the change in AUC (\u0394AUC), continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the training cohort, model A achieved an AUC of 0.852 (95% confidence interval [CI] 0.818\u20130.887), whereas model B demonstrated significantly improved discrimination with an AUC of 0.888 (95% CI 0.859\u20130.917;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). Model B also showed favorable calibration (Hosmer\u2013Lemeshow,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.594) and a lower Brier score (0.134 vs. 0.153). At the optimal cutoff value of 0.135 for FAR (determined by the Youden index), model B achieved a sensitivity of 0.864 and a specificity of 0.740 for predicting CAPO. In the external validation cohort, model B maintained robust discrimination (AUC 0.856, 95% CI 0.808\u20130.904) and outperformed model A (AUC 0.798, 95% CI 0.740\u20130.857;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.003). Across the entire cohort, the addition of FAR resulted in a \u0394AUC of 0.010 (95% CI 0.002\u20130.019;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.013), a continuous NRI of 0.397 (95% CI 0.268\u20130.526;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), and an IDI of 0.022 (95% CI 0.012\u20130.032;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.004). Subgroup and sensitivity analyses confirmed the robustness of these findings.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FAR provides statistically significant incremental prognostic value for predicting CAPO, a composite of severe peripartum events. From an anesthesiology perspective, FAR \u22650.135 alerts to coagulopathy and systemic inflammation, supporting cautious neuraxial anesthesia, early invasive monitoring, and escalated perioperative care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1853375","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:55:33Z","timestamp":1780030533000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Incremental prognostic value of the fibrinogen\u2212to\u2212albumin ratio for adverse perinatal outcomes in preeclampsia: a dual\u2212center retrospective cohort study"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaoyun","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaijian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University","place":["Xiamen, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Fujian Medical University Union Hospital","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Zhangzhou Affiliated Hospital of Fujian Medical University","place":["Zhangzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/23779608231207223","article-title":"Cardiovascular disease risk factors awareness among women with a history of preeclampsia in Jordan","volume":"9","author":"Kassab","year":"2023","journal-title":"SAGE Open Nurs"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.42343","article-title":"Estimated prevalence of risk factors for preeclampsia among individuals giving birth in the US in 2019","volume":"5","author":"Wheeler","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276206","article-title":"Impact of preeclampsia\/eclampsia on hemorrhagic and ischemic stroke risk: a 17 years follow-up nationwide cohort study","volume":"17","author":"Chuang","year":"2021","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.14486","article-title":"Assessment of all-cause cancer incidence among individuals with preeclampsia or eclampsia during first pregnancy","volume":"4","author":"Serrand","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-06142-y","article-title":"Prevalence of maternal mortality causes based on ICD-MM: a systematic review and meta-analysis","volume":"23","author":"Alipour","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/aog.0000000000005022","article-title":"Incidence, indications, risk factors, and outcomes of emergency peripartum hysterectomy worldwide","volume":"141","author":"Kallianidis","year":"2022","journal-title":"Obstetrics Gynecology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.12659\/msm.943772","article-title":"Risk factors for postpartum hemorrhage in severe pre-eclampsia: a retrospective single-centre study of 1953 cases","volume":"30","author":"Yingzi","year":"2024","journal-title":"Med Sci Monit"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1394120","article-title":"Editorial: Adverse outcomes of preeclampsia: from mother to baby, pregnancy to postpartum","volume":"15","author":"Bakrania","year":"2024","journal-title":"Front Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000547538","article-title":"Preeclampsia and onset of renal disorders in the long-term period following pregnancy","author":"Auger","year":"2025","journal-title":"Am J Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073632","article-title":"Neurodevelopmental disruptions in children of preeclamptic mothers: pathophysiological mechanisms and consequences","volume":"25","author":"Gonz\u00e1lez-Rojas","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-024-06568-y","article-title":"Preeclampsia as a possible risk factor for memory impairment, anxiety- and depressive-like behavior in offspring","volume":"241","author":"V\u00e9lez-God\u00ednez","year":"2024","journal-title":"Psychopharmacology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.123.21061","article-title":"Long-term impacts of preeclampsia on the cardiovascular system of mother and offspring","volume":"80","author":"Yang","year":"2023","journal-title":"Hypertension"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.122.18730","article-title":"Peripartum and long-term maternal cardiovascular health after preeclampsia","volume":"80","author":"Giorgione","year":"2022","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1144170","article-title":"Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum","volume":"10","author":"Bisson","year":"2023","journal-title":"Front Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1038\/s41467-025-58157-y","article-title":"Molecular subtyping of hypertensive disorders of pregnancy","volume":"16","author":"Elovitz","year":"2025","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald","year":"2021","journal-title":"EBioMedicine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"S1059","DOI":"10.1016\/j.ajog.2020.09.038","article-title":"Complement activation and regulation in preeclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome","volume":"226","author":"Burwick","year":"2020","journal-title":"Am J Obstetrics Gynecology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.61622\/rbgo\/2025rbgo39","article-title":"The accuracy of the fullPIERS model in predicting adverse maternal and perinatal outcomes: evidence from a tertiary care maternity unit","volume":"47","author":"Gomes","year":"2025","journal-title":"Rev Bras Ginecologia e Obstetr\u00edcia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004509","article-title":"Consecutive prediction of adverse maternal outcomes of preeclampsia, using the PIERS-ML and fullPIERS models: a multicountry prospective observational study","volume":"22","author":"Yang","year":"2025","journal-title":"PloS Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","volume":"377","author":"von Dadelszen","year":"2010","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.117.10318","article-title":"Assessment of the fullPIERS risk prediction model in women with early-onset preeclampsia","volume":"71","author":"Ukah","year":"2018","journal-title":"Hypertension (Dallas Tex 1979)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21180","article-title":"Development and validation of prediction models for risks of complications in early-onset pre-eclampsia (PREP): a prospective cohort study","volume":"21","author":"Thangaratinam","year":"2017","journal-title":"Health Technol Assess"},{"key":"B24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12916-017-0827-3","article-title":"Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models","volume":"15","author":"Thangaratinam","year":"2017","journal-title":"BMC Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4072487","article-title":"Safety of COVID-19 vaccines during pregnancy: a systematic review and meta-analysis","volume":"41","author":"Ciapponi","year":"2023","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.0638","article-title":"The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: an individual participant meta-analysis","volume":"171","author":"Voysey","year":"2017","journal-title":"JAMA Pediatr"},{"key":"B27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/01.aoa.0000489468.07157.ab","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263443","article-title":"sFlt-1\/PlGF ratio for prediction of preeclampsia in clinical routine: a pragmatic real-world analysis of healthcare resource utilisation","volume":"17","author":"Dathan-Stumpf","year":"2022","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqae129.378","article-title":"The predictive value of sFlt-1\/PlGF ratio for postpartum preeclampsia","volume":"162","author":"Li","year":"2024","journal-title":"Am J Clin Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-019-2399-z","article-title":"A cross sectional study to assess the sFlt-1:PlGF ratio in pregnant women with and without preeclampsia","volume":"19","author":"Pant","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.719","article-title":"GW29-e1674 blood sFlt-1\/PlGF ration is a promising method to predict preeclampsia: a meta-analysis of prospective studies","volume":"72","author":"Lin","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12071678","article-title":"Association between fibrinogen-to-albumin ratio and prognosis of hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"12","author":"Hung","year":"2022","journal-title":"Diagnostics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2478\/jce-2023-0009","article-title":"Are NLR, PLR, and elevated uric acid levels predictive of preeclampsia","volume":"9","author":"Corduneanu","year":"2023","journal-title":"J Cardiovasc Emergencies"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.757643","article-title":"Upregulation of fibrinogen-like 1 expression contributes to reducing the progression of preeclampsia","volume":"9","author":"Cheng","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Arif","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13598","article-title":"Inflammasome activation in preeclampsia and intrauterine growth restriction","volume":"88","author":"Zorlu","year":"2022","journal-title":"Am J Reprod Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/nu14102087","article-title":"An overview of obesity, cholesterol, and systemic inflammation in preeclampsia","volume":"14","author":"Alston","year":"2022","journal-title":"Nutrients"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-016-0199-3","article-title":"Dynamics of fibrinogen in acute phases of trauma","volume":"5","author":"Mineji","year":"2017","journal-title":"J Intensive Care"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.09.007","article-title":"Mechanisms that may underlie a causal association between SARS-COV-2 infection and preeclampsia","volume":"226","author":"Agustin","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2022.2160627","article-title":"Elevated liver enzymes and adverse outcomes among patients with preeclampsia with severe features","volume":"36","author":"Greiner","year":"2023","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206048","article-title":"Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease\u2014a review","volume":"11","author":"S\u0142awek-Szmyt","year":"2022","journal-title":"J Clin Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1515\/jpm-2016-0040","article-title":"Comparison of ductus venosus doppler and cerebroplacental ratio for the prediction of adverse perinatal outcome in high\u2010risk pregnancies before and after 34\u2009weeks","volume":"102","author":"Morales-Rosell\u00f3","year":"2023","journal-title":"Acta Obstetricia Gynecologica Scandinavica"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2022.2040968","article-title":"Role of derived neutrophil-to-lymphocyte ratio, uric acid-to-creatinine ratio and delta neutrophil index for predicting neonatal outcomes in pregnancies with preeclampsia","volume":"42","author":"Yak\u0131\u015ft\u0131ran","year":"2022","journal-title":"J Obstetrics Gynaecology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/09513590.2019.1706085","article-title":"The role of progestogen supplementation (dydrogesterone) in the prevention of preeclampsia","volume":"36","author":"Tskhay","year":"2019","journal-title":"Gynecological Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.70510","article-title":"Unraveling preeclampsia: Is the fibrinogen-to-albumin ratio the key to early risk assessment","volume":"172","author":"U\u011furcan","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22861","article-title":"Predictive value of soluble fms\u2010like tyrosine kinase\u20101 against placental growth factor for preeclampsia in a Chinese pregnant women population","volume":"33","author":"Yu","year":"2019","journal-title":"J Clin Lab Anal"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1853375\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:55:43Z","timestamp":1780030543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1853375\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":47,"alternative-id":["10.3389\/fendo.2026.1853375"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1853375","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1853375"}}